- Home
- Plastic Surgery
- Aesthetic Surgery
- augmentation mammoplasty
- Breast implant removals
- Mastopexy
- Buttock lift
- Jaw reshaping
- Dermabrasion
- Blepharoplasty
- Rhytidectomy
- Forehead lift
- Hair Transplantation
- Lip augmentation
- Lipoplasty
- Lower body lift
- Rhinoplasty
- Thigh lift
- Abdominoplasty
- Brachioplasty
- Botox injections
- Cellulite treatment
- Chemical peel
- Facial rejuvenation
- Laser skin resurfacing
- Laser treatment of leg veins
- Vaginal rejuvenation
- Aesthetic Surgery
- Dentistry (Odontology)
- More Topics (Coming Soon)
Subscribe to Updates
Browsing: Phase
PHILADELPHIA — An oral, nonaddictive sodium channel blocker safely relieved moderate to severe acute pain after surgery, according to phase III data that could support regulatory…
Vertex PharmaceuticalsInvestigational non-opioid pain treatment suzetrigin has a cleaner safety profile than standard pain medications and even placebo, according to full Phase III data presented over…
Pictured: Vertex Pharmaceuticals office in Boston, Massachusetts/iStock, hapapapa Vertex Pharmaceuticals announced Tuesday that the non-opioid pain treatment VX-548 completed three Phase III studiescausing significant pain reduction…
Caliway Announces Phase 2 CBL-514 Study for the Treatment of Cellulite That Met All Primary and Secondary Endpoints
By Medi
CBL-514 is the first product to treat cellulite in raised areas. Currently, there is no effective and safe treatment for cellulite on the market. The global…
Pictured: Vertex Pharmaceuticals office in Boston, Massachusetts/iStock, hapapapa Vertex Pharmaceuticals announced Tuesday that its non-opioid pain treatment VX-548 completed three Phase III studiescausing significant pain reduction…
Caliway Announces Completion of Subject Enrollment in Phase 2 Study-Stage 2 CBL-0201EFP Evaluation of CBL-514 in the Treatment of Cellulite
By Medi
TAIPEI, September 18, 2023 /PRNewswire/ — Caliway Biopharmaceuticals (Caliway), a biopharmaceutical company focused on innovative medical aesthetics and inflammatory medicine discovery of small molecule therapeutics, announced…
Ross Kemp, 59, reveals why he would never get a hair transplant as he reflects on his new phase in life as the oldest dad at school
By Medi
Ross Kemp revealed why he would never get a hair transplant as he reflected on a new phase in his life in a candid new interview…
Teikoku Pharma USA announces positive results from Phase 2 clinical trial of TPU-006, a non-opioid pain management patch in abdominoplasty. USA – English India – English
By Medi
SAN JOSE, September 6, 2023 /PRNewswire/ — Teikoku Pharma USA, a global pharmaceutical company, today announced positive results from its Phase 2 proof-of-concept study of TPU-006,…
Teikoku Pharma USA announces positive results from Phase 2 clinical trial of TPU-006, a non-opioid pain management patch in abdominoplasty.
By Medi
SAN JOSE, September 6, 2023 /CNW/ — Teikoku Pharma USA, a global pharmaceutical company, today announced positive results from its Phase 2 proof-of-concept study of TPU-006,…